期刊论文详细信息
| Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism? New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation | |
| Article | |
| 关键词: PROTHROMBIN COMPLEX CONCENTRATE; COST-EFFECTIVENESS; DIRECT THROMBIN; DABIGATRAN; WARFARIN; NONADHERENCE; SAFETY; ADHERENCE; REVERSAL; THERAPY; | |
| DOI : 10.1161/CIRCULATIONAHA.111.031153 | |
| 来源: SCIE | |
【 授权许可】
Free